Cancer encompasses a large number of diseases that are characterized by a division and uncontrolled growth of the cells, which have the ability to divide themselves into the organ where they originated.

When the tumor becomes malignant, they can travel through the blood and lymphatic fluid to other, more distant organs and grow there, leading to metastasis.

IDIBELL has two cancer research programs (comprising 28 teams of researchers), who tackle the disease from the most basic experimental point of view to the clinic: molecular mechanisms and new therapies, epigenetics, and Population and prevention studies.